Abstract:Chemotherapeutic agents often cause severe side effects because they produce a similar cytotoxicity in both cancerous and healthy cells. In this study, a rational strategy was implemented to take advantage of a combination of both tumor microenvironment-sensitive polypeptides (TMSP) and folate to create a more selective and efficient drug delivery system to target cancer cells. TMSP and folate were conjugated to the distal ends of DSPE-PEG2000-maleimide and DSPE-PEG5000-amine to create DSPE-PEG2000-TMSP and DSPE-PEG5000-folate, respectively, which were incorporated onto the surface of a docetaxel-loaded nanostructured lipid carrier (F/TMSP-DTX-NLC). TMSP are comprised of polycationic cell-penetrating peptides (CPP) and polyanionic inhibitory peptides, which are coupled via a proteinase-sensitive cleavable linker. The linker can be cleaved in the presence of matrix metalloprotease-2 and -9 (MMP-2/9). TMSP provides the ability to enhance specific cancer cellular uptake after selectively unmasking polyanionic inhibitory peptides in MMP-2/9 protease-oversecretion tumor tissue, whereas in circulation, the penetration is shielded. The folate moiety binds selectively to folate receptor-positive tumors. The cleaved dual-modified nanocarriers are then taken up by the tumor cells via both receptor-mediated endocytosis and CPP penetrating action to overcome the higher interstitial pressure in the tumor. The nanocarrier system demonstrated a small size, high encapsulation efficiency (>95%), sustained release and targeted delivery. The strong cellular uptake and cytotoxic activity of dual-modified F/TMSP-DTX-NLC in KB, HT-1080, MCF-7 and A549 cells verified the correlation with folate receptor expression and MMP-2/9 secretion. The remarkable penetration into KB and HT-1080 multicellular tumor spheroids confirmed that the temporary mask of the polyanionic inhibitory peptide in TMSP does not disturb the penetration ability of CPP in the tumor microenvironment with abundant proteases. Furthermore, the active targeting and triggered activation exhibited higher antitumor efficacy and lower systemic toxicity with the KB tumor model in nude mice compared to the nonmodified DTX-NLC and Taxotere(®). These results suggested that the application of combined TMSP and folate modifications may be an approach in the selectively targeted delivery of anticancer drugs with low systemic toxicity.

[Tumor cell targetability of folate receptor-mediated mitoxantrone albumin nanoparticles].

Studies on preparation of folate-conjugated mitoxantrone-loaded albumin nanoparticles and its property in vitro

Investigation on a Potential Targeting Drug Delivery System Consisting of Folate, Mitoxantrone and Human Serum Albumin

Preparation and Functional Characterization of Tumor-Targeted Folic Acid-Chitosan Conjugated Nanoparticles Loaded with Mitoxantrone

Folate-modified Bexarotene-Loaded Bovine Serum Albumin Nanoparticles As a Promising Tumor-Targeting Delivery System.

Preparation of a Folate-Mediated Tumor Targeting Ultraparamagnetic Polymeric Micelles and Its in Vitro Experimental Study

In vitro evaluation of a Folate-bovine serum albumin-doxorubicin conjugate.

Preparation of Folic Acid-Conjugated, Doxorubicin-Loaded, Magnetic Bovine Serum Albumin Nanospheres and Their Antitumor Effects in Vitro and in Vivo

Uptake of Folate-Conjugated Albumin Nanoparticles to the SKOV3 Cells

Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.

Mitoxantrone- and Folate-TPGS2k Conjugate Hybrid Micellar Aggregates to Circumvent Toxicity and Enhance Efficiency for Breast Cancer Therapy.

Folate Receptor-Targeted Albumin Nanoparticles Based on Microfluidic Technology to Deliver Cabazitaxel

[Study on the Preparation of Folate-Conjugated Albumin Nanoparticles].

Folate Functionalized Polymeric Micelle As Hepatic Carcinoma-Targeted, Mri-Ultrasensitive Delivery System of Antitumor Drugs

Chemotherapeutic Drug Delivery to Cancer Cells Using a Combination of Folate Targeting and Tumor Microenvironment-Sensitive Polypeptides.

Folate-receptor Mediated Ph/reduction-Responsive Biomimetic Nanoparticles for Dually Activated Multi-Stage Anticancer Drug Delivery.

In Vivo MR Imaging of Folate-Receptor Expression with the Folate-Specific Nanospheres in a C6 Glioblastoma Model

Pharmacokinetics and Tissue Distribution of Folate-Decorated Human Serum Albumin Loaded With Nano-Hydroxycamptothecin for Tumor Targeting

Preparation and characterization of dual-targeting nanostructure lipid carriers loading mitoxantrone hydrochloride for bone tumor

Isomeric Folate-Conjugated Polymeric Micelles Bind to Folate Receptors and Display Anticancer Effects.

Fe3 O4 Nanoparticles Synthesis With Folic Acid-coupling and Marked Tumor Experimental Research